Cargando…

Targeting CXCR2 inhibits the progression of lung cancer and promotes therapeutic effect of cisplatin

BACKGROUND: Drug-resistance and severe side effects of chemotherapeutic agents result in unsatisfied survival of patients with lung cancer. CXCLs/CXCR2 axis plays an important role in progression of cancer including lung cancer. However, the specific anti-cancer mechanism of targeting CXCR2 remains...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Yuan, Mo, Fei, Li, Qingfang, Han, Xuejiao, Shi, Houhui, Chen, Siyuan, Wei, Yuquan, Wei, Xiawei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019513/ https://www.ncbi.nlm.nih.gov/pubmed/33814009 http://dx.doi.org/10.1186/s12943-021-01355-1

Ejemplares similares

Antitumor and Radiosensitization Effects of a CXCR2 Inhibitor in Nasopharyngeal Carcinoma
por: Liu, Xiaobei, et al.
Publicado: (2021)

DNA-PK inhibition by M3814 enhances chemosensitivity in non-small cell lung cancer
por: Wang, Manni, et al.
Publicado: (2021)

Inhibition of ROCK ameliorates pulmonary fibrosis by suppressing M2 macrophage polarisation through phosphorylation of STAT3
por: Li, Qingfang, et al.
Publicado: (2022)

mRNA vaccine: a potential therapeutic strategy
por: Wang, Yang, et al.
Publicado: (2021)

Cancer vaccines as promising immuno-therapeutics: platforms and current progress
por: Liu, Jian, et al.
Publicado: (2022)

Ikaros Proteins in Tumor: Current Perspectives and New Developments
por: Xia, Ruolan, et al.
Publicado: (2021)

Opportunities and challenges in the nanoparticles for nucleic acid therapeutics: the first approval of an RNAi nanoparticle for treatment of a rare disease
por: Wei, Xiawei, et al.
Publicado: (2019)

BTK inhibitors in the treatment of hematological malignancies and inflammatory diseases: mechanisms and clinical studies
por: Alu, Aqu, et al.
Publicado: (2022)

Ammonia promotes the proliferation of bone marrow-derived mesenchymal stem cells by regulating the Akt/mTOR/S6k pathway
por: Liu, Yu, et al.
Publicado: (2022)

Epigenetic regulation of macrophages: from homeostasis maintenance to host defense
por: Chen, Siyuan, et al.
Publicado: (2019)

Biomaterial-assisted biotherapy: A brief review of biomaterials used in drug delivery, vaccine development, gene therapy, and stem cell therapy
por: Han, Xuejiao, et al.
Publicado: (2022)

The role of lysosome in regulated necrosis
por: Alu, Aqu, et al.
Publicado: (2020)

cGAS-STING pathway in cancer biotherapy
por: Wang, Yang, et al.
Publicado: (2020)

JMJD6 in tumor-associated macrophage regulates macrophage polarization and cancer progression via STAT3/IL-10 axis
por: Chen, Siyuan, et al.
Publicado: (2023)

Role of the CCL2‐CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting
por: Xu, Maosen, et al.
Publicado: (2021)

Multifunctional regulatory protein connective tissue growth factor (CTGF): A potential therapeutic target for diverse diseases
por: Fu, Minyang, et al.
Publicado: (2022)

CXCR7-mediated progression of osteosarcoma in the lungs
por: Goguet-Surmenian, E, et al.
Publicado: (2013)

Inhibition of FGF‐FGFR and VEGF‐VEGFR signalling in cancer treatment
por: Liu, Guihong, et al.
Publicado: (2021)

G-CSF Inhibits Pulmonary Fibrosis by Promoting BMSC Homing to the Lungs via SDF-1/CXCR4 Chemotaxis
por: Zhao, Fei-yan, et al.
Publicado: (2020)

The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis
por: Huang, Yuhe, et al.
Publicado: (2022)

TNF‐α augments CXCR2 and CXCR3 to promote progression of renal cell carcinoma
por: Sun, Kuang‐Hui, et al.
Publicado: (2016)

Mitochondrial DNA in the regulation of innate immune responses
por: Fang, Chunju, et al.
Publicado: (2015)

AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications
por: Zhu, Chenjing, et al.
Publicado: (2019)

Knockdown of ATG4A inhibits breast cancer progression and promotes tamoxifen chemosensitivity by suppressing autophagy
por: Li, Qingfang, et al.
Publicado: (2022)

Cellular Toxicity and Immunological Effects of Carbon-based Nanomaterials
por: Yuan, Xia, et al.
Publicado: (2019)

JMJD3 in the regulation of human diseases
por: Zhang, Xiangxian, et al.
Publicado: (2019)

Inhibition of CXCR2 plays a pivotal role in re-sensitizing ovarian cancer to cisplatin treatment
por: Henriques, Taciane Barbosa, et al.
Publicado: (2021)

Lipopolysaccharide Promotes Choroidal Neovascularization by Up-Regulation of CXCR4 and CXCR7 Expression in Choroid Endothelial Cell
por: Feng, Yi-fan, et al.
Publicado: (2015)

Jumonji domain‐containing protein 6 protein and its role in cancer
por: Yang, Jing, et al.
Publicado: (2020)

Molecular mechanisms and clinical management of cancer bone metastasis
por: Wang, Manni, et al.
Publicado: (2020)

CCL5/CCR5 axis in human diseases and related treatments
por: Zeng, Zhen, et al.
Publicado: (2021)

Role of tumor gene mutations in treatment response to immune checkpoint blockades
por: Wang, Manni, et al.
Publicado: (2019)

Application of Baculovirus Expression Vector System (BEVS) in Vaccine Development
por: Hong, Qiaonan, et al.
Publicado: (2023)

HLA-DPA1 overexpression inhibits cancer progression, reduces resistance to cisplatin, and correlates with increased immune infiltration in lung adenocarcinoma
por: Shi, Ke, et al.
Publicado: (2023)

Inhibition of stromal CXCR4 impairs development of lung metastases
por: D’Alterio, Crescenzo, et al.
Publicado: (2012)

Therapeutic inhibition of CXCR1/2: where do we stand?
por: Sitaru, Sebastian, et al.
Publicado: (2023)

MicroRNA-137 inhibits tumor growth and sensitizes chemosensitivity to paclitaxel and cisplatin in lung cancer
por: Shen, Hua, et al.
Publicado: (2016)

CXCR4 antagonists suppress small cell lung cancer progression
por: Taromi, Sanaz, et al.
Publicado: (2016)

Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer
por: Zeng, Zhen, et al.
Publicado: (2023)

Cancer-associated fibroblasts promote the progression of endometrial cancer via the SDF-1/CXCR4 axis
por: Teng, Fei, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_q9mmbs0c5c6de2fmlckb5p1a24